The necessary measures for the development of domestic innovation of Medicine and Pharmacy leading experts (representatives of the largest companies) were discussed at the round table. Experts agreed that drug developers should be supported economically, and all their achievements - headline.
According to market research company Cegedim Strategic Data, by 2020, the potential volume of the pharmaceutical market in the world amount to $ 75 billion. They predict that by this time will be formed by more than 800 small innovative farmakompany specialists will release to the market of at least 100 unique drugs and the ratio of sales of original products and generics (them more available analogs) through 8 years of 60% to 40%. In the near future, domestic farmakompanii may be able to declare itself seriously. "If our efforts to create a general picture of the future of the Russian health care to succeed, we will go more efficient way" - said Larisa Popovich, director of the Institute of Health Economics, School of Economics.
In our country, there are already companies that come to work in the experts from European countries. For example, in running the company "Pharmstandard" project "Generium" work biotechnologists from 5 different countries. However, all is not well as it might seem at first glance. The existing health care system needs to be changed as soon as possible, because it depends on it investments in innovative medicine. To participate in the reforms should involve experts in the clinical diseases, epidemiologists and pharmacists.
In assessing the prospects of scientific research and its applications affected by changes in the structure of morbidity, epidemiological and pandemic risks. This connection is necessary to track, for the most efficient and investment - attractive innovative pharmaceutical industry.
Industry News
Go back to the main page
No comments:
Post a Comment